After Successfully Deploying Electronic Health
Record to All Primary DOD Locations in the Continental United
States, Leidos Partnership Now Deploys MHS GENESIS Globally with
Waves LANDSTUHL/LAKENHEATH and at
Fort Buchanan and Guantanamo
Bay
RESTON,
Va., Oct. 17, 2023 /PRNewswire/ -- The Leidos
Partnership for Defense Health (LPDH) today announced it
successfully delivered the MHS GENESIS electronic health record to
an additional 9,000 Department of Defense (DOD) clinicians and
providers as part of its first Outside of the Contiguous United
States (OCONUS) deployment (Waves LANDSTUHL/LAKENHEATH). The current system
deployment spans 10 Military Treatment Facilities (MTFs) across
Europe and the United Kingdom. Additionally, LPDH deployed
MHS GENESIS to users at Fort Buchanan, Puerto Rico and Guantanamo Bay, Cuba.
"We achieved a major milestone earlier this calendar year when
we successfully deployed MHS GENESIS to all primary DOD locations
in the United States and we're now
thrilled to roll out the system internationally with our first
OCONUS deployments in Wave Europe," said Liz Porter, Leidos Health Group President. "We
are also on track to deploy to Pacific locations before the end of
the year and we continue to refine the system's capabilities along
the way to meet our customer's evolving requirements."
LPDH continues to strengthen MHS GENESIS with a focus on
furthering the quality of care. In addition to improving overall
platform scalability and performance, the partnership made key
system improvements. For example, users are now able to query
and report immunizations to state registries through improved
connectivity with the Centers for Disease Control and Prevention
(CDC). Allergy and medication data are also now available within
the system's dental solution.
LPDH enhanced MHS Video Connect, the system's virtual health
capability, to streamline and improve secure video appointments.
New system tools and processes are now available to satisfy annual
periodic health assessments and to meet individual medical
readiness standards. Finally, the partnership optimized the
system's workflow to improve recurring treatments and care for
dialysis patients and added an important interface enabling message
exchange with overseas MTFs.
LPDH designed and developed MHS GENESIS, the Military Health
System's new electronic health record, and has been providing
program management and technical expertise to the Program Executive
Office Defense Healthcare Management Systems (PEO DHMS) since
2015.
With this latest overseas DOD wave deployment, the MHS GENESIS
system is now operational at over 3,500 locations and now reaches
over seven million DOD beneficiaries. MHS GENESIS is 91% deployed
to DOD garrison facilities and will next deploy to Far East
locations in October 2023.
"We're proud of this successful deployment to our first OCONUS
waves," noted Chris Ruefer, Deputy
Program Executive Officer for DHMS. "We're excited to further
enhance patient and provider experiences."
MHS GENESIS is being deployed across the continental
United States and overseas through
a total of 23 waves, with each wave targeting a specific region.
This approach enables the Department of Defense to take full
advantage of lessons learned from prior waves to maximize
subsequent wave efficiencies.
About Leidos
Leidos is a Fortune 500® technology, engineering, and science
solutions and services leader working to solve the world's toughest
challenges in the defense, intelligence, civil and health markets.
Leidos' 46,000 employees support vital missions for government and
commercial customers. Headquartered in Reston, Va., Leidos reported annual revenues
of approximately $14.4 billion for
the fiscal year ended December 30,
2022. For more information, visit www.leidos.com.
About LPDH
The Leidos Partnership consists of four core partners - Leidos,
Oracle Cerner Corporation, Accenture and Henry Schein One - along with approximately 35
supporting businesses. Together, they deliver an integrated,
modern, secure health information system that includes an
electronic health record system, a dental system, identity
management capability, Cybersecurity, and other supporting
components. MHS GENESIS will serve as the system of record,
providing a single, integrated solution for managing the health and
military readiness of the force for DOD and the Department of
Veterans Affairs, among other agencies.
Certain statements in this announcement constitute
"forward-looking statements" within the meaning of the rules and
regulations of the U.S. Securities and Exchange Commission
(SEC). These statements are based on management's current
beliefs and expectations and are subject to significant risks
and uncertainties. These statements are not guarantees of
future results or occurrences. A number of factors could cause
our actual results, performance, achievements, or industry results
to be different from the results, performance, or achievements
expressed or implied by such forward-looking statements. These
factors include, but are not limited to, the "Risk Factors" set
forth in Leidos' Annual Report on Form 10-K for the fiscal year
ended December 30, 2022, and other
such filings that Leidos makes with the SEC from time to time.
Readers are cautioned not to place undue reliance on such
forward-looking statements, which speak only as of the date hereof.
Leidos does not undertake to update forward-looking statements to
reflect the impact of circumstances or events that arise after the
date the forward-looking statements were made.
Contact:
Melissa Dueñas
(571) 526-6850
Melissa.L.Duenas@leidos.com
Thomas Doheny
(571) 474-4735
Dohenyt@leidos.com
Lauren Reddington
(202) 924-2226
Lauren.A.Reddington@leidos.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/leidos-partnership-deploys-mhs-genesis-overseas-in-first-of-two-planned-oconus-waves-301958436.html
SOURCE Leidos